Evidence map›Paper›PMID 38453214›Full record

ArticleRMD open2024

Hyperactivation and altered selection of B cells in patients with paediatric Sjogren's syndrome.

Alessandra Boni, Rebecca Nicolai, Ivan Caiello, Francesca Marinaro, Luciapia Farina, Denise Pires Marafon, Rita Carsetti, Fabrizio De Benedetti, Claudia Bracaglia, Emiliano Marasco

Open access · goldAbstract read
In one paragraph

Article in RMD open, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 26% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 3 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 1 institution in 2 countries.

Alessandra Boni *Division of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Rebecca Nicolai *Division of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Ivan CaielloLaboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Roma, Italy.
Francesca MarinaroLaboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Roma, Italy.
Luciapia FarinaLaboratory of Immuno-Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Roma, Italy.
Denise Pires MarafonDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Rita CarsettiB cell unit, Immunology Research Area, Bambino Gesù Children's Hospital, IRCCS, Roma, Italy.
Fabrizio De BenedettiDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.
Claudia BracagliaDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy claudia.bracaglia@opbg.net.ORCID 0000-0002-9834-9619
Emiliano MarascoDivision of Rheumatology, Bambino Gesù Children's Hospital, IRCCS, Rome, Italy.ORCID 0000-0001-5346-3357
Bambino Gesù Children's Hospital · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesPaediatric Sjögren's syndrome (pSS) is a rare chronic autoimmune disorder, characterised by inflammation of exocrine glands. B cell hyperactivation plays a central role in adult-onset Sjogren. This study was designed to analyse B cell and T cell phenotype, levels of BAFF, and selection of autoreactive B cells in patients with pSS.

methodsA total of 17 patients diagnosed with pSS and 13 healthy donors (controls) comparable for age were enrolled in the study. B cell and T cell subsets and frequency of autoreactive B cells in peripheral blood were analysed by flow cytometry. Levels of BAFF were analysed by ELISA.

resultsThe relative frequency of total B cells, transitional, naïve and switched memory B cells was similar between pSS patients and controls. In patients with pSS, we observed a reduction in the frequency of unswitched memory B cells, an increased frequency of atypical memory B cells and an expansion of PD1

conclusionsOur results point to a hyperactivation of B cells in pSS. Current therapies do not seem to affect B cell abnormalities, suggesting that novel therapies targeting specifically B cell hyperactivation need to be implemented for paediatric patients.

Indexed as

Autoimmune DiseasesSjogren's SyndromeAdultB-LymphocytesChildHumansT-Lymphocyte SubsetsAutoantibodiesB cellsCytokines

Identifiers

PMID38453214
PMCPMC10921545
OpenAlexW4392559865

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.